![Scott Barrett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Barrett
Nessuna posizione attualmente
Profilo
Scott Barrett formerly worked at Incyte Corp., as Executive Director-Medical Affairs from 2016 to 2019, Infinity Pharmaceuticals, Inc., as Senior Director-Clinical Development from 2014 to 2016, and Immuneering Corp., as Chief Medical Officer from 2019 to 2025.
Dr. Barrett received his undergraduate degree from The Johns Hopkins University and doctorate degree from the University of Miami.
Precedenti posizioni note di Scott Barrett
| Società | Posizione | Fine |
|---|---|---|
| IMMUNEERING CORPORATION | Direttore Tecnico/Scientifico/R&S | 20/03/2025 |
| INCYTE CORPORATION | Corporate Officer/Principal | 01/11/2019 |
| INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/06/2016 |
Formazione di Scott Barrett
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
13
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immuneering Corp.
 Immuneering Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, focuses on the oncology and neuroscience product candidates | Health Technology |
